We note that it has not been demonstrated that either the re-expression of TP53 and/or RB1 in SCLC or the downregulation of these tumor suppressor genes in NSCLC may be specifically correlated with the CHK1- and ATR inhibitor response. The gene discussed is CHEK1; the disease is small cell lung carcinoma.